£500K
The health tech company surpassed £500k on Crowdcube with backing from more than 100 investors.
.png)
Digostics builds an at-home oral glucose tolerance test for diabetes detection.
Digostics develops GTT at home, an oral glucose intolerance test designed to replace clinic visits. The CE marked platform supports diabetes screening for patients in the UK and international markets.
James Jackson
CEO and Founder
The health tech company surpassed £500k on Crowdcube with backing from more than 100 investors.